中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

41 records (took 0.018 seconds)

    Packet Delay and Bandwidth Consideration for Real-time and Non-real-time Applications for QoS Oriented Network Selection in IEEE 802.16e WiMAX Networks
    4.
    发明专利
    Packet Delay and Bandwidth Consideration for Real-time and Non-real-time Applications for QoS Oriented Network Selection in IEEE 802.16e WiMAX Networks 未知

    公开(公告)号：AU2020102588A4

    公开(公告)日：2020-11-19

    申请号：AU2020102588

    申请日：2020-10-03

    Applicant: BAJPAI BHAVNA DR ,  DHIMAN GAURAV DR ,  GUPTA SWETA MRS ,  KOHLI RASHI MS ,  KUMAR YOGESH DR ,  NAIR RAJIT MR ,  S GOMATHI DR ,  S SENTHILKUMAR MR ,  SONI MUKESH MR ,  SINGAR CHANDRA PRAKASH MR

    Inventor： KOHLI RASHI ,  S SENTHILKUMAR ,  KUMAR YOGESH ,  S GOMATHI ,  SONI MUKESH ,  SINGAR CHANDRA PRAKASH ,  GUPTA SWETA ,  DHIMAN GAURAV ,  BAJPAI BHAVNA ,  NAIR RAJIT

    IPC: H04W48/18 ,  H04W40/12

    Abstract: Packet Delay and Bandwidth Consideration for Real-time and Non-real-time Applications for QoS Oriented Network Selection in IEEE 802.16e WiMAX Networks The IEEE 802.16 standard WiMAX (Worldwide Interoperability for Microwave Access) network is one of the widely used 4G networks since it provides high-speed data over a wide coverage area. In this, the standard 802.16e supports both fixed and mobile nodes in which the quality of service (QoS) will get degraded due to frequent and false handoffs which should be minimized for getting uninterrupted services. The handoff is a process of disconnecting the mobile device from the old base station and reconnecting it with the new base station. Generally, the handoff will occur during the mobility when the received signal strength goes below the acceptable level. But in the recent scenario, the handoff may be triggered for many reasons such as poor QoS, monetary cost, interference, battery level, etc. In the literature, many handoff schemes are proposed for WiMAX networks but no work considered the parameters such as mobile velocity, ongoing application type, and network status, tolerable uplink packet delay, tolerable downlink packet delay, required uplink bandwidth, and required downlink bandwidth all together. Also, most of the handoff of schemes in the literature are suitable for mobile devices and not suitable for fixed devices. In this invention, we have proposed a handoff method for selecting the best base station in the WiMAX network by considering many parameters such as RSS, the velocity of the mobile, network status, application type, tolerable uplink packet delay, tolerable downlink packet delay, required uplink bandwidth, and required downlink bandwidth. Moreover, based on the ongoing application's type (i.e., real time or non-real-time) the preference will be given to either base station with minimum packet delay or base station with maximum bandwidth for performing a handoff. This proposed method is suitable not only for mobile devices it is also suitable for fixed devices which helps in avoiding the ungainful handoffs and in selecting the best WiMAX base station among the available candidates thereby it helps in improving the quality of service. loosing QOS for No time = f Yes Avoid Unbeneficial Estimatethecnrrent network Handoff and Stayin condition and mobilevelocity the current BS No if the eurret network condition is h ad Scan the near by BSs with require ed QoS and add it in list B No Bf I~i > Do HO w ith any BS in B, Yes with Maximum RSS If Velocity = Vt > e yes Is Real-Time- No Application? Do HO with any BS in B Do HO with any BS in B, with with Minimum Packet Delay Maximum Available Bandwidth Fig. 2

    Zusammensetzung von pflanzlichen Therapeutika zur Behandlung von Herz-Kreislauf-Erkrankungen
    10.
    发明专利
    Zusammensetzung von pflanzlichen Therapeutika zur Behandlung von Herz-Kreislauf-Erkrankungen 未知

    公开(公告)号：DE202025100808U1

    公开(公告)日：2025-03-07

    申请号：DE202025100808

    申请日：2025-02-17

    Applicant: AHMED RAFI ,  BARWANT MUKUL MACHHINDRA ,  DWIVEDI RAKESH KUMAR ,  HUMANE PITAMBAR TULSHIRAM ,  KURKUTE PRATIBHA ,  PANDEY POOJA OMPRAKASH ,  PARAMESWARAN KOUSALYA ,  SHRIVASTAVA RUCHITA ,  SHUKLA CHANDRA PRAKASH ,  YADAV HIMANSHU

    IPC: A61K36/82 ,  A61K31/734 ,  A61K36/16 ,  A61K36/185 ,  A61K36/53 ,  A61K36/535 ,  A61K36/68 ,  A61K36/81 ,  A61P9/00

    Abstract: Phytotherapeutische Zusammensetzung für die Behandlung von kardiovaskulären Erkrankungen, umfassend:10-30 Gew.-% eines flavonoidreichen Extrakts, der aus Ginkgo biloba gewonnen wird und standardisiert ist, um mindestens 90 % reinen Flavonoidgehalt zu enthalten;5-20 Gew.-% eines terpenoidreichen Extrakts, der aus Weißdornbeeren (Crataegus oxyacantha) gewonnen wird und standardisiert ist, um mindestens 85% reinen Terpenoidgehalt zuenthalten;15-25 Gew.-% eines aus Perilla frutescens-Samen gewonnenen Komplexes mehrfach ungesättigter Fettsäuren, der ein Verhältnis von Omega-3-zu Omega-6- Fettsäuren von 3:1 aufweist;10-20 Gew.-% eines polyphenolischen Extrakts aus Blättern des Grünen Tees (Camellia sinensis), standardisiert auf einen Gehalt von mindestens 95% reiner Polyphenole;5-15 Gew.-% eines Stickoxid-verstärkenden Alkaloidextrakts aus Roter Bete (Beta vulgaris), standardisiert auf einen Gehalt von mindestens 80 % reiner Alkaloide; 4-12 Gew.-% eines Extrakts aus Terminalia arjuna, der reich an Flavonoiden und Triterpenoiden ist, um die Herzfunktion zu verbessern und den oxidativen Stress zu reduzieren;3-15 Gew.-% eines Extrakts aus Withania somnifera, der Withanolide zur Senkung des Bluthochdrucks und des Cholesterinspiegels enthält;2-10 Gew.-% eines Extrakts aus Ocimum sanctum, der Eugenol und Rosmarinsäure enthält, die entzündungshemmend und antithrombozytär wirken; 4-12 Gew.-% eines Extrakts aus Punica granatum, der Polyphenole und Ellagitannine für die Verbesserung der Endothelfunktion liefert;2-10 Gew.-% eines löslichen Ballaststoffkomplexes, der aus Flohsamenschalen (Plantago ovata) gewonnen wird, um die Bioverfügbarkeit und die gastrointestinale Verträglichkeit zu verbessern; undein pharmazeutisch akzeptabler Träger oder Hilfsstoff, ausgewählt aus der Gruppe bestehend aus mikrokristalliner Cellulose, Magnesiumstearat und Siliciumdioxid.

Patent Agency Ranking